Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years - John E. Harris; Amit G. Pandya; Mark Lebwohl; Iltefat H. Hamzavi; Pearl Grimes; Alice B. Gottlieb; Howard L. Sofen; Angela Y. Moore; Mingyue Wang; Deanna Kornacki; Kathleen Butler; David Rosmarin (Wiley, 2024)